Global Cochlear Implant Systems Market : Asia-Pacific will account for higher market share of more than 30% driven due to owing to the high prevalence of hearing defects in the region: Global Market Analysis 2013 – 2017 and Forecast 2018 – 2024

Market Scenario

Global Cochlear Implant Systems Market is likely to grow at CAGR of around 7.8% and will exceed over USD 3.4 billion by 2024. Global Cochlear Implant Systems Market growth is primarily driven by increasing incidence of hearing loss in infants and adults. An increasing number of aging population are suffering from hearing loss due to age related changes in the inner and middle ear. Hearing loss is a problem which shows disability and morbidity in the aged population circle. Cochlear implants help aged people to regain their hearing and fully participate in day to day activities. Global Cochlear Implant Systems Market Overview, By Region: Asia-Pacific expected to have larger market due to high penetration of implants, conducive health infrastructure of the Asia-Pacific, and presence of a large patient base in the region North America was the second largest market in 2017 and is expected to observe a significant growth in forecasting period. Global Cochlear Implant Systems Market Overview, By Products: Global Cochlear Implant Systems Market Unilateral implant industry segment had highest Global Cochlear Implant Systems Market share in 2016. The market has highest share is due to the individuals prefer these kinds of implants due to high costs of the products of bilateral implantation and also due to different risks expected from the surgery. Bilateral implant industry segment is expected to grow during the forecast years due to growing number of implants accepted by the individuals are for both the ears. The advantages of this implant including additional speech perception also drive the Global Cochlear Implant Systems Market for bilateral implants through the forecast period. Global Cochlear Implant Systems Market Overview, By End User: Adult business segment is expected to grow at a high rate during the forecast period. The higher growth rate is due to increasing ageing population and increasing hearing loss problems. Paediatric business segment held high market share in 2016. The segment is also expected to grow through the forecast period due to the implementation of new born hearing screening programs in several countries enabling the identification of profound hearing loss among infants. Global Cochlear Implant Systems Market Overview, By Market Players: Improving the healthcare sector significantly has been always the focus of tactical resolutions taken by the key players in the Cochlear Implant Systems market. Some of the companies operating in Cochlear Implant Systems market are MED-EL, Gaes Medica, Oticon Medical, PENTAX Medical, William Demant Holding A/S, LSVT Global, Inc., Cochlear Limited, EBS Healthcare, Sonova, and Nurotron Biotechnology Co., Ltd. Global Cochlear Implant Systems Market Background: Increasing problems of babies born with hearing defects is driving the market for cochlear implant systems. According to WHO records, out of 1000 babies born per year approximately 1 to 3 new-borns are expected to have hearing problems. Thus, there is a high need for a cochlear implant each year. Market Segmentation • By Products o Unilateral Implants o Bilateral Implants • By End-User o Adult o Pediatric The above data will be provided for following regions/countries from 2013-2024 (USD Million) • North America o U.S. o Canada • Europe o Germany o UK o France o Spain o Italy • Asia Pacific o China o India o Japan o Australia • Latin America o Argentina o Brazil o Mexico • Middle East and Africa o South Africa What information is covered in report? • Actual market numbers from 2013-2017, estimates and forecasts from 2018 to 2024 • Detailed market segmentation and market share analysis of each segment • Impact analysis of various drivers and trends • Market segmentation and landscape • Competitive landscape, 2017. Wearable Medical Devices Market Latin America: Forecast 2026

Table of Contents

Chapter 1 Research Methodology .1.1. Research Methodology .1.2. Market definition .1.3. Assumptions and Acronyms Used .1.4. Data Sources .1.4.1. Secondary .1.4.1.1. Paid .1.4.1.2. Unpaid .1.4.2. Primary Chapter 2 Executive Summary .2.1. Global Cochlear Implant Systems market overview .2.1.1. By Products .2.1.2. By End-User Chapter 3 Global Cochlear Implant Systems Industry Insights .3.1. Market segmentation and scope of study .3.2. Market Drivers and their impact analysis .3.2.1. Market Drivers .3.2.1.1. Increasing focus on aesthetic appearance .3.2.2. Market Restrains .3.2.2.1. Additional cost on the second implant restrains adoption .3.3. Market share analysis .3.3.1. By Products .3.3.2. By End-User .3.4. Reimbursements scenario .3.4.1. U.S. .3.4.2. Europe .3.5. Regulations landscape .3.5.1. U.S. .3.5.2. Europe .3.6. Competitive analysis .3.6.1. Key strategic initiatives .3.6.2. Regional presence .3.6.3. Product overview .3.7. Porter’s analysis .3.8. PESTEL analysis Chapter 4 Cochlear Implant Systems Market, By Products .4.1. Key segment trends .4.2. Unilateral Implants .4.2.1. Market size, by region, 2013 - 2024 .4.3. Bilateral Implants .4.3.1. Market size, by region, 2013 - 2024 Chapter 5 Cochlear Implant Systems Market, By End-User .5.1. Key segment trends .5.2. Adult .5.2.1. Market size, by region, 2013 - 2024 .5.3. Pediatric .5.3.1. Market size, by region, 2013 - 2024 Chapter 6 Cochlear Implant Systems Market, By Region .6.1. Key regional trends .6.2. North America .6.2.1. Market size, by country, 2013 – 2024 .6.2.2. Market size, by products, 2013 – 2024 .6.2.3. Market size, by end-use, 2013 – 2024 .6.2.4. U.S. .6.2.4.1. Market size, by products, 2013 – 2024 .6.2.4.2. Market size, by end-use, 2013 – 2024 .6.2.5. Canada .6.2.5.1. Market size, by products, 2013 – 2024 .6.2.5.2. Market size, by end-use, 2013 – 2024 .6.3. Europe .6.3.1.1. Market size, by country, 2013 – 2024 .6.3.1.2. Market size, by products, 2013 – 2024 .6.3.1.3. Market size, by end-use, 2013 – 2024 .6.4. Germany .6.4.1.1. Market size, by products, 2013 – 2024 .6.4.1.2. Market size, by end-use, 2013 – 2024 .6.5. UK .6.5.1.1. Market size, by products, 2013 – 2024 .6.5.1.2. Market size, by end-use, 2013 – 2024 .6.6. France .6.6.1.1. Market size, by products, 2013 – 2024 .6.6.1.2. Market size, by end-use, 2013 – 2024 .6.7. Spain .6.7.1.1. Market size, by products, 2013 – 2024 .6.7.1.2. Market size, by end-use, 2013 – 2024 .6.8. Italy .6.8.1.1. Market size, by products, 2013 – 2024 .6.8.1.2. Market size, by end-use, 2013 – 2024 .6.9. Asia Pacific .6.9.1.1. Market size, by country, 2013 – 2024 .6.9.1.2. Market size, by products, 2013 – 2024 .6.9.1.3. Market size, by end-use, 2013 – 2024 .6.10. India .6.10.1.1. Market size, by products, 2013 – 2024 .6.10.1.2. Market size, by end-use, 2013 – 2024 .6.11. China .6.11.1.1. Market size, by products, 2013 – 2024 .6.11.1.2. Market size, by end-use, 2013 – 2024 .6.12. Japan .6.12.1.1. Market size, by products, 2013 – 2024 .6.12.1.2. Market size, by end-use, 2013 – 2024 .6.13. Australia .6.13.1.1. Market size, by products, 2013 – 2024 .6.13.1.2. Market size, by end-use, 2013 – 2024 .6.14. Latin America .6.14.1.1. Market size, by country, 2013 – 2024 .6.14.1.2. Market size, by products, 2013 – 2024 .6.14.1.3. Market size, by end-use, 2013 – 2024 .6.15. Argentina .6.15.1.1. Market size, by products, 2013 – 2024 .6.15.1.2. Market size, by end-use, 2013 – 2024 .6.16. Brazil .6.16.1.1. Market size, by products, 2013 – 2024 .6.16.1.2. Market size, by end-use, 2013 – 2024 .6.17. Mexico .6.17.1.1. Market size, by products, 2013 – 2024 .6.17.1.2. Market size, by end-use, 2013 – 2024 .6.18. Middle East and Africa .6.18.1.1. Market size, by country, 2013 – 2024 .6.18.1.2. Market size, by products, 2013 – 2024 .6.18.1.3. Market size, by end-use, 2013 – 2024 .6.19. South Africa .6.19.1.1. Market size, by products, 2013 – 2024 .6.19.1.2. Market size, by end-use, 2013 – 2024 Chapter 7 Company Profiles .7.1. MED-EL .7.1.1. Company overview .7.1.2. Key financials .7.1.3. Product landscape .7.1.4. Strategic initiatives .7.1.5. SWOT analysis .7.2. Cochlear Limited .7.2.1. Company overview .7.2.2. Key financials .7.2.3. Product landscape .7.2.4. Strategic initiatives .7.2.5. SWOT analysis .7.3. Oticon Medical .7.3.1. Company overview .7.3.2. Key financials .7.3.3. Product landscape .7.3.4. Strategic initiatives .7.3.5. SWOT analysis .7.4. William Demant Holding A/S .7.4.1. Company overview .7.4.2. Key financials .7.4.3. Product landscape .7.4.4. Strategic initiatives .7.4.5. SWOT analysis .7.5. LSVT Global, Inc. .7.5.1. Company overview .7.5.2. Key financials .7.5.3. Product landscape .7.5.4. Strategic initiatives .7.5.5. SWOT analysis .7.6. PENTAX Medical .7.6.1. Company overview .7.6.2. Key financials .7.6.3. Product landscape .7.6.4. Strategic initiatives .7.6.5. SWOT analysis .7.7. EBS Healthcare .7.7.1. Company overview .7.7.2. Key financials .7.7.3. Product landscape .7.7.4. Strategic initiatives .7.7.5. SWOT analysis .7.8. Sonova .7.8.1. Company overview .7.8.2. Key financials .7.8.3. Product landscape .7.8.4. Strategic initiatives .7.8.5. SWOT analysis .7.9. Gaes Medica .7.9.1. Company overview .7.9.2. Key financials .7.9.3. Product landscape .7.9.4. Strategic initiatives .7.9.5. SWOT analysis .7.10. Nurotron Biotechnology Co., Ltd. .7.10.1. Company overview .7.10.2. Key financials .7.10.3. Product landscape .7.10.4. Strategic initiatives .7.10.5. SWOT analysis

Inquiry Before Buying

Request Sample

About This Report

Report ID 9327
Category Healthcare
Publisher Name
No of Pages
Total Views
Published Date
Contact Us
Call Now